Position in ABBV
as of Jun 30, 2026
· filed Aug 21, 2026
Position Value
$869,667
+$118,022 QoQ
Shares Held
3,456
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.54%
of 13F equity value
Holder Rank
#2,676
of 4,153 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Bernard Wealth Management Corp. holds $12,061,954 across 8 Drug Manufacturers - General names. ABBV ranks #2 (7.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
9,000 | $10,794,870 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
3,456 | $869,667 | |
| 3 | MRK |
Merck & Co., Inc.
|
1,608 | $206,628 | |
| 4 | AMGN |
Amgen Inc
|
379 | $137,243 | |
| 5 | JNJ |
Johnson & Johnson
|
100 | $25,397 | |
| 6 | PFE |
Pfizer Inc
|
808 | $19,456 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
50 | $6,317 | |
| 8 | BIIB |
Biogen Inc.
|
11 | $2,376 |
All Filings in ABBV
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $869,667 | 3,456 | Shares | Sole | 2026-08-21 | |
| 2026-03-31 | $751,645 | 3,456 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $789,661 | 3,456 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $800,202 | 3,456 | Shares | Sole | 2025-10-14 | |
| 2025-06-30 | $641,502 | 3,456 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $731,224 | 3,490 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $622,660 | 3,504 | Shares | Sole | 2025-02-13 | |
| No filing history on record for this holder in this stock. | ||||||